Figure S4 from Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy

2026 Open access

Read full text
Authors: Gracia Gracia, Enyuan Cao, Daniel Yuen, Vilena D.M. Ferreira, Moore Z. Chen, Danielle Senyschyn, Justine D. Mintern, Angus P. R. Johnston, David W. Kang, Orlagh M. Feeney, Christopher J.H. Porter
DOI: 10.1158/2326-6066.31484156
Cited by: 0

Abstract

Gating strategies for αCTLA mAb uptake (via detection of IgG2b Fc portion) by CTLA4+ T cells at the TDLN of CT26/HAS tumour model.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Proteoglycans and glycosaminoglycans research Immunotherapy and Immune Responses

Publication details

Publication date
4 March 2026
Language
EN